CDKN2A and cancer: INK4a encodes the p16INK4a protein, which normally blocks cancer by inhibiting oncogenic cyclin-dependent kinases 4 and 6 (CDK4/6) and activating the Retinoblastoma 1 (RB1) tumor suppressor (Figure 2) [10,11,12,13,14].